Introduction
============

Primary open-angle glaucoma (POAG, OMIM [137760](http://www.ncbi.nlm.nih.gov/omim?term=137760)) is the most common form of glaucoma, which is the leading cause of irreversible vision loss worldwide \[[@r1]\]. POAG is characterized by progressive loss of retinal ganglion cells and visual field in the absence of a known secondary cause. Well recognized risk factors for the development of POAG are elevated intraocular pressure (IOP), positive family history of glaucoma, refractive error, and African ancestry \[[@r2],[@r3]\]. As a complex genetic disorder, there is a strong hereditary component to POAG; first-degree relatives of affected individuals have a 7--10 fold higher risk of developing POAG than the general population \[[@r4]-[@r6]\]. Several regions in the human genome have been linked to POAG \[[@r2]\]. To date, several genes including myocilin (*MYOC*), optineurin (*OPTN*), WD repeat domain 36 (*WDR36*), and cytochrome P450, family 1, subfamily B, polypeptide 1 (*CYP1B1*) have been implicated in POAG, but mutations in these genes account for less than 10% of POAG cases \[[@r7]-[@r10]\].

Linkage analyses are useful in determining regions of interest for complex diseases. However, linkage regions often contain dozens or even hundreds of genes. Although it is possible to sequence all genes within a linked locus using high-throughput second-generation sequencing, it is important to prioritize any identified sequence changes for further follow-up. Prioritizing genes for further analysis requires the use of other methods to provide complementary information, in an approach which we have termed genomic convergence \[[@r11]\]. This approach combines multiple forms of genome-wide data such as linkage, gene expression analysis and association studies to identify and prioritize candidate susceptibility genes for complex disorders \[[@r11],[@r12]\]. Genome-wide association studies have been widely used to identify the risk factors for POAG and exfoliation glaucoma \[[@r13]-[@r15]\] but generate a very large number of candidate susceptibility genes. Gene expression data from ocular tissues will help in the interpretation and prioritization of this large number of candidate genes.

Expression profiling is commonly performed by either microarray or serial analysis of gene expression (SAGE) \[[@r16],[@r17]\]. SAGE involves direct measurement of mRNA transcripts and generates a non-biased gene expression profile without regard to selection of a reference sample \[[@r16],[@r18]\]. Advantages of SAGE include the power to identify fine variations in expression levels and the ability to detect novel transcripts without prior knowledge of gene sequence. It thus provides unique advantages over the traditional microarray-based approach for expression studies. In contrast, microarray gene expression profiling is based on the use of pre-designed probes for selected genes, or genome annotation \[[@r19]\]. Microarray analysis then measures the level of gene expression relative to a reference sample (e.g., tissue of a different type, or from a different individual) \[[@r17],[@r19],[@r20]\].

Non-SAGE expression analyses have been reported with human trabecular meshwork (HTM) and/or cultured HTM cells. The first analysis of gene expression in the trabecular meshwork was performed in 1990: Tripathi and coworkers examined levels of HLA expression in HTM \[[@r21]\]. Gonzales and coworkers \[[@r22]\] performed the first genome-wide expression analysis a decade later. They constructed a PCR-amplified cDNA library containing 1,060 clones from a non-glaucomatous HTM. Several genome-wide analyses have subsequently expanded our knowledge of gene expression in HTM \[[@r23]-[@r32]\]. To date, most studies have used a microarray-based approach with primary or cultured HTM cells. We report here the analysis of HTM obtained from three individuals using Long SAGE (using 17 base pair sequence tags) \[[@r33]\]. The present work aims to further our understanding of gene expression in the HTM, in support of an eventual understanding of the pathophysiology underlying determinants of ocular outflow facility.

Methods
=======

Procurement of tissue and RNA extraction
----------------------------------------

Donor human eyes were obtained from the North Carolina Eye Bank (NCEB, Winston-Salem, NC). Immediately after enucleation, donated eyes were incised through the pars plana, the globe was immersed in RNALater (Ambion, Austin, TX), and was placed in storage at 4 °C. Within 24 h of death the trabecular meshwork (TM) was dissected using an operating microscope and stored at −80 °C until RNA isolation. De-identified clinical information and medical records were reviewed. There was no history of glaucoma, steroid use, or ocular trauma. Details regarding the donors and donor eyes are listed in [Table 1](#t1){ref-type="table"}. Medical record review and dissection of the TM was performed by a glaucoma trained subspecialist (R.R.A.).

###### Human Donor eyes used for SAGE libraries.

  **Sample ID**   **Age**   **Race**   **Gender**   **PMI (h)**   **Ocular history**   **PCD**               **Notes**
  --------------- --------- ---------- ------------ ------------- -------------------- --------------------- ---------------------------------------------
  201             25        Eur        F            1.08          No                   Anoxic brain injury   Anorexia, bulimia, depression, heart murmur
  625             42        Eur        F            7.98          Yes                  Pneumonia             Proliferative DR
  784             68        Eur        M            2.92          No                   Lung cancer           Prostatectomy, COPD, HTN, OA

Eur: European descent; F: female; M: male; PMI: post mortem interval; PCD: Primary cause of death; DR: diabetic retinopathy; COPD: chronic obstructive pulmonary disease; HTN: hypertension; OA: osteoarthritis.

Total RNA was extracted from the TM of one eye per donor using TRIzol (Invitrogen, Carlsbad, CA) followed by isopropanol precipitation. RNA quality was assessed by visualization in denaturing agarose gel electrophoresis and the 260 nm/280 nm ratio of absorbance. RNA concentration was calculated according to the absorbance measurement at 260 nm.

Synthesis and analysis of SAGE libraries
----------------------------------------

Individual SAGE libraries from the 3 HTM samples were constructed with 5 µg RNA using the I-SAGE Long kit from Invitrogen. NlaIII was used as the anchoring enzyme. Standard methodologies were used according to the manufacturer's recommendations \[[@r34]\]. SAGE libraries were sequenced at Agencourt Bioscience (Beverly, MA).

The [SAGE 2000](http://www.sagenet.org) software version 4.5 was used to extract and tabulate SAGE tags (17 base pairs in length) for each library. SAGE tags that matched to multiple genomic locations were removed. To minimize the background noise and false-positive results, only unique tags with a minimum of 2 counts in at least one of the three libraries were used for a gene match. The best gene match for each reliable tag was assigned using resources available at the Cancer Genome Anatomy Project (CGAP) SAGE Genie website \[[@r35]\] with the recent version of SAGE Genie library file (released November, 2009). Specifically, SAGE Genie's "Best gene for the tag" table was used to match each long tag to its best [Unigene](http://www.ncbi.nlm.nih.gov/unigene) cluster match. In most cases, a non-redundant assignment was made. [Unigene](http://www.ncbi.nlm.nih.gov/unigene) clusters were mapped to the human genome assembly. Tag sequences, tag counts, and gene associations were stored in a relational database for subsequent analysis using Microsoft Access software (Redmond, WA). All SAGE data collected through this project has been has been deposited in [NEIBank](http://neibank.nei.nih.gov) \[[@r36]\]. This [expression data](http://eyebrowse.cit.nih.gov) is freely available to researchers.

Results
=======

SAGE libraries
--------------

Three SAGE libraries were produced, one from each donor, according to the standard protocol. Donor eyes were obtained within 1, 3, or 8 h postmortem from Caucasian donors of European descent that ranged in age from 25 to 68 years ([Table 1](#t1){ref-type="table"}). One individual (sample 625) had a history of proliferative diabetic retinopathy. None had any history of glaucoma, steroid use, or elevated intraocular pressure.

A total of 298,834 total tags were extracted from the SAGE libraries. Characteristics of the tags found in the three SAGE libraries are shown in [Table 2](#t2){ref-type="table"}. There were 107,325 unique tags collectively in the three separate libraries. Each library contained approximately 6,000 mapped unique [Unigene](http://www.ncbi.nlm.nih.gov/unigene) clusters. Altogether, 10,329 unique [Unigene](http://www.ncbi.nlm.nih.gov/unigene) clusters were mapped. After excluding singleton tags, the proportion of unmapped (orphan) tags ranged from 21% to 26%, which is comparable to the 20%--30% reported from other SAGE libraries \[[@r12],[@r37],[@r38]\]. Unique tags mapping to more than 2 [Unigene](http://www.ncbi.nlm.nih.gov/unigene) clusters were removed from further analysis. Library 784 was sequenced to a greater depth than the other libraries, and thus contained the largest number of unique tags.

###### Summary of the three HTM SAGE libraries.

  **Donor**   **Total tags**   **Unique tags \***   **Unique tag counts 1**   **Unique tag counts ≥2**   **Unique Unigene clusters**   **Redundant Unigene clusters‡**   **Orphan tags﻿§**
  ----------- ---------------- -------------------- ------------------------- -------------------------- ----------------------------- --------------------------------- -------------------
  201         96842            37212                27350                     9862                       6830 (69%)                    949 (10%)                         2083 (21%)
  625         88126            36092                27106                     8986                       6214 (69%)                    911 (10%)                         1861 (21%)
  784         113866           58216                48660                     9556                       5200 (54%)                    1895 (20%)                        2461 (26%)
  Total       298834           107325†              92702†                    17993†                     10329 (58%)†                  2371 (13%)†                       5293 (29%)†

\*Unique tags: Number of different tag sequences occurring in each library; ‡ Redundant Unigene clusters: unique tags with at least 2 counts in one library that map to more than 2 loci in human genome (NCBI build 37); §Orphan tags: unique tags with at least 2 counts in one library that do not map to any known Unigene cluster; † The total number here is for all unique tags in all three libraries instead of the sum-up. The percentage was calculated based on the sum of unique tags with at least 2 counts.

The 650 genes that each comprise more than 0.01% of the total transcriptome (30 total tags or greater) were categorized by gene function using the [PANTHER](http://www.pantherdb.org/) classification system (Protein ANalysis THrough Evolutionary Relationships) \[[@r39]\], as shown in [Figure 1](#f1){ref-type="fig"}. The main functional categories included cell adhesion, cell structure and mobility, apoptosis, signal transduction, transport, and protein metabolism.

![Functional categories based on the molecular process for top 650 genes with more than 30 tags in all three libraries. The gene ontology analysis was performed using [PANTHER](http://www.pantherdb.org/) classification system (Protein ANalysis THrough Evolutionary Relationships).](mv-v17-885-f1){#f1}

We next examined genes that were expressed in multiple libraries: 56% were expressed in at least two libraries, while 48% were expressed in all three libraries ([Figure 2](#f2){ref-type="fig"}). Expressed genes were mapped to known glaucoma loci, including GLC1B through GLC1D, GLC1F, and GLC1H through GLC1N. [Appendix 1](http://www.molvis.org/molvis/v17/a99/app-1.pdf) lists only those genes that were found in all three libraries, while [Appendix 2](http://www.molvis.org/molvis/v17/a99/app-2.pdf) lists those that were expressed in any single library.

![Venn's diagram to compare the genes expressed in the three libraries \#201, \#625, and \#784. All the percentage calculation was based on the total number of unique Unigene clusters combined from all three libraries.](mv-v17-885-f2){#f2}

The most abundantly expressed tags were those associated with components of ribosomal proteins. Because these house-keeping genes are commonly observed in SAGE libraries from various tissue types, they were removed from further analysis. The 40 remaining most highly expressed tags, with tag counts ranging from 200 to 3,511, are shown in [Table 3](#t3){ref-type="table"}. The most highly expressed non-ribosomal tag is an unnamed transcribed locus (UniGene Hs.703108). Two proteins considered to be HTM markers were represented by more than 120 tags in each library: *MGP* (matrix GLA protein) and *CHI3L1* (Chitinase 3-like 1) \[[@r40]\]. Three of the four genes reported to cause POAG, *MYOC*, *OPTN* and *CYP1B1*, were expressed in all three libraries, while *WDR36* was expressed in only one. Flotillin and gamma-synuclein, proteins which interact with myocilin, were expressed in all samples \[[@r41],[@r42]\]. *Rab8* (ras-related protein Rab-8A) and *TBK1* (TANK-binding kinase 1), which interact with *OPTN,* were also expressed in all three libraries \[[@r2],[@r43],[@r44]\]. Sequence tags from 2 recently identified glaucoma-related genes, lysyl oxidase 1 (*LOXL1*; associated with exfoliation glaucoma), and caveolin 1 and caveolin 2 (associated with POAG) were expressed in at least two libraries \[[@r13],[@r15]\]. The complete expression profiles can be found at [Eyebrowse](http://eyebrowse.cit.nih.gov).

###### Forty mapped genes with most highly expressed SAGE tags in the three HTM libraries (After the removal of ribosomal proteins).

  **Tag**             **Tag counts (%†)**   **\# of libraries**   **Unigene ID**   **Gene symbol**   **Gene description**                                              **Location**
  ------------------- --------------------- --------------------- ---------------- ----------------- ----------------------------------------------------------------- ---------------
  TTCATACACCTATCCCC   3511 (1.17)           3                     Hs.703108                          Transcribed locus                                                 
  CCCTACCCTGTTACCTT   1594 (0.53)           3                     Hs.522555        APOD              Apolipoprotein D                                                  3q26.2-qter
  CACCTAATTGGAAGCGC   1254 (0.42)           3                     Hs.150324        LOC100133315      Similar to hCG1640299                                             11q13.4
  TGATTTCACTTCCACTC   1143 (0.38)           3                     Hs.634715                          Transcribed locus                                                 
  GCCCCTGCTGACACGAG   1090 (0.36)           3                     Hs.433845        KRT5              Keratin 5                                                         12q12-q13
  CAACTAATTCAATAAAA   990 (0.33)            3                     Hs.436657        CLU               Clusterin                                                         8p21-p12
  TACCTGCAGAATAATAA   977 (0.33)            3                     Hs.416073        S100A8            S100 calcium binding protein A8                                   1q21
  GTTGTGGTTAATCTGGT   775 (0.26)            3                     Hs.534255        B2M               Beta-2-microglobulin                                              15q21-q22.2
  GTGGCCACGGCCACAGC   721 (0.24)            3                     Hs.112405        S100A9            S100 calcium binding protein A9                                   1q21
  GGAGTGTGCTCAGGAGT   717 (0.24)            3                     Hs.504687        MYL9              Myosin, light chain 9, regulatory                                 20q11.23
  ACTTTTTCAAAAAAAAA   648 (0.22)            3                     Hs.349570        NCRNA00182        Non-protein coding RNA 182                                        Xq13.2
  CACTACTCACCAGACGC   612 (0.20)            3                     Hs.631491                          Transcribed locus                                                 
  TACCATCAATAAAGTAC   605 (0.20)            3                     Hs.544577        GAPDH             Glyceraldehyde-3-phosphate dehydrogenase                          12p13
  ACCCTTGGCCATAATAT   555 (0.19)            3                     Hs.465808        HNRNPM            Heterogeneous nuclear ribonucleoprotein M                         19p13.3-p13.2
  TACATAATTACTAATCA   520 (0.17)            3                     Hs.523789        NEAT1             Nuclear paraspeckle assembly transcript 1 (non-protein coding)    11q13.1
  ACTAACACCCTTAATTC   491 (0.16)            3                     Hs.631494        LOC100131754      Similar to NADH dehydrogenase subunit 2                           1p36.33
  GTAGGGGTAAAAGGAGG   451 (0.15)            3                     Hs.631492                          Transcribed locus                                                 
  TGCCTGCACCAGGAGAC   422 (0.14)            3                     Hs.304682        CST3              Cystatin C                                                        20p11.21
  TAATAAAGAATTACTTT   407 (0.14)            3                     Hs.654570        KRT15             Keratin 15                                                        17q21.2
  GAAATACAGTTGTTGGC   388 (0.13)            3                     Hs.654447        CTSD              Cathepsin D                                                       11p15.5
  CAAGCATCCCCGTTCCA   375 (0.13)            2\*                   Hs.408470                          Transcribed locus                                                 
  TACAGTATGTTCAAAGT   370 (0.12)            3                     Hs.518525        GLUL              Glutamate-ammonia ligase (glutamine synthetase)                   1q31
  CATATCATTAAACAAAT   360 (0.12)            3                     Hs.479808        IGFBP7            Insulin-like growth factor binding protein 7                      4q12
  ACACAGCAAGACGAGAA   343 (0.11)            3                     Hs.721789                          Transcribed locus                                                 
  ATTTGAGAAGCCTTCGC   336 (0.11)            3                     Hs.703130                          Transcribed locus                                                 
  CCACAGGAGAATTCGGG   325 (0.11)            3                     Hs.201446        PERP              PERP, TP53 apoptosis effector                                     6q24
  GTGCTGAATGGCTGAGG   323 (0.11)            3                     Hs.632717        MYL6              Myosin, light chain 6, alkali, smooth muscle and non-muscle       12q13.2
  GTGTGTTTGTAATAATA   296 (0.10)            3                     Hs.369397        TGFBI             Transforming growth factor, beta-induced, 68 kDa                  5q31
  CAGGTTTCATATTCTTT   230 (0.08)            3                     Hs.483444        CXCL14            Chemokine (C-X-C motif) ligand 14                                 5q31
  ACGGAACAATAGGACTC   226 (0.08)            3                     Hs.446429        PTGDS             Prostaglandin D2 synthase 21 kDa (brain)                          9q34.2-q34.3
  GATGCCGGCACAAAACT   223 (0.07)            3                     Hs.146559        ANGPTL7           Angiopoietin-like 7                                               1p36.3-p36.2
  CCCCCTGGATCAGGCCA   223 (0.07)            3                     Hs.275243        S100A6            S100 calcium binding protein A6                                   1q21
  GATGTGCACGATGGCAA   219 (0.07)            3                     Hs.654380        KRT14             Keratin 14                                                        17q12-q21
  TAAGTAGCAAACAGGGC   214 (0.07)            3                     Hs.643683        ITM2B             Integral membrane protein 2B                                      13q14.3
  TCGAAGCCCCCATCGCT   211 (0.07)            3                     Hs.631498        LOC100293090      Similar to DC24                                                   
  GTGACCTCCTTGGGGGT   210 (0.07)            3                     Hs.433901        COX8A             Cytochrome c oxidase subunit 8A (ubiquitous)                      11q12-q13
  CTAGCCTCACGAAACTG   205 (0.07)            3                     Hs.514581        ACTG1             Actin, gamma 1                                                    17q25
  CCCTGGGTTCTGCCCGC   205 (0.07)            3                     Hs.433670        FTL               Ferritin, light polypeptide                                       19q13.33
  GACCAGCTGGCCAAGAC   201 (0.07)            3                     Hs.642660        C10orf116         Chromosome 10 open reading frame 116                              10q23.2
  GTTACCACAAGCCACAA   200 (0.07)            3                     Hs.436037        MYOC              Myocilin, trabecular meshwork inducible glucocorticoid response   1q23-q24

†The percentage was based on the total number of tags in all three libraries (298834). \* This 17 bp tag was not expressed in the library \#625.

Discussion
==========

This is the first detailed SAGE gene expression profile reported for human TM tissue. Expression patterns in this study are consistent with the current understanding of normal trabecular meshwork physiology. Many expressed genes in the TM are related to extracellular matrix function, cell metabolism/defense/transport, cell signaling, and cell structure/adhesion \[[@r45]\]. As expected, genes involved in typical TM maintenance functions (including collagens, matrix metalloproteinases \[MMPs\], and tissue inhibitor of metalloproteinases \[TIMPs\]) are highly expressed, while those genes associated with stress or pathology are not highly expressed.

SAGE expression profiling of glaucomatous human TM would be a valuable complement to this study and could assist the exploration of disease-specific effects on tissue expression. TM tissue is available from POAG patients undergoing trabeculectomy surgery; however, surgical samples are small and yield insufficient RNA for SAGE analysis. Prospective enrollment of well documented glaucoma patients will be required to obtain tissue for such studies. Most patients with glaucoma have a history of medical or surgical treatment, which complicates interpretation of gene expression patterns.

Identifying candidate genes for POAG is a multifactorial and multistep process. Family-based linkage analysis has implicated more than fourteen loci, but only a few susceptibility genes have been identified \[[@r2]\]. The TM-specific gene expression data reported here contributes to the understanding of normal TM function, and constitutes a valuable resource to help prioritize and identify genes involved in the etiology of POAG.
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List of genes within known GLC1 loci that are expressed in all three HTM libraries. To access the data, click or select the words "[Appendix 1](http://www.molvis.org/molvis/v17/a99/app-1.pdf)." This will initiate the download of a compressed (pdf) archive that contains the file.

List of genes within known GLC1 loci that are expressed in at least one donor HTM library. To access the data, click or select the words "[Appendix 2](http://www.molvis.org/molvis/v17/a99/app-2.pdf)." This will initiate the download of a compressed (pdf) archive that contains the file.
